SummitTX Capital »

C4 Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $28k 11k 2.63

More positions owned by SummitTX Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Warner Bros Discovery Com Ser A (WBD)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Asml Hldg Nv N Y Registry Shs (ASML)
MKS Instruments (MKSI)
State Str Spdr S&p Midcap 40 Utser1 S&pdcrp (MDY)
Griffon Corporation (GFF)
Meritage Homes Corporation (MTH)
Cabot Oil & Gas Corporation (CTRA)
Topbuild (BLD)
NVR (NVR)
Cisco Systems (CSCO)
Ge Aerospace Com New (GE)
NVIDIA Corporation (NVDA)

View all positions for SummitTX Capital

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
Vanguard Group
Vanguard Capital Management
Soleus Capital Management
Two Sigma Investments
Daniel D. Thurber
Citadel Advisors
Goldman Sachs Group
Bank of America Corporation
Squadron Capital Management
BlackRock
Silverarc Capital Management

View all funds holding C4 Therapeutics